Solid Tumour Clinical Trial
Official title:
The Compatibility of Nivestim™ Under Cytotoxic Chemotherapy in the Treatment of Malignant Diseases
The purpose of this study is to observe the tolerability, safety and efficacy of preventative treatment using Nivestim™ in patients receiving cytotoxic chemotherapy for cancer.
This is a non-interventional, descriptive, national, multi-site, longitudinal and prospective observational study with in-patients adults or minors undergoing cytotoxic chemotherapy, being treated prophylactically with Nivestim™ in order to reduce the duration of neutropenia and to reduce the incidence of chemotherapy-induced Febrile neutropenia (FN). ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02648490 -
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers
|
Phase 1 | |
| Recruiting |
NCT01226407 -
Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile
|
Phase 1 | |
| Withdrawn |
NCT04891718 -
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
|
Early Phase 1 | |
| Completed |
NCT01447732 -
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT04958226 -
A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours
|
Phase 1 | |
| Completed |
NCT04121910 -
A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole
|
Phase 1 | |
| Terminated |
NCT01219543 -
A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.
|
Phase 1 | |
| Completed |
NCT01489826 -
A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours
|
Phase 1 | |
| Terminated |
NCT01516645 -
Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Unknown status |
NCT01046461 -
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
|
Phase 2 | |
| Completed |
NCT02086721 -
Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor
|
Phase 1 | |
| Active, not recruiting |
NCT00467779 -
Study of GDC-0973/XL518 in Patients With Solid Tumors
|
Phase 1 | |
| Completed |
NCT01300468 -
Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors
|
Phase 1 |